老年2型糖尿病健康状态分层框架的应用与研究进展

doi:10.3969/j.issn.1003-9198.2023.11.023

摘要/Abstract

中图分类号:

R 587.1

宗前兴, 莫永珍. 老年2型糖尿病健康状态分层框架的应用与研究进展[J]. 实用老年医学, 2023, 37(11): 1170-1175.

[1] 国家老年医学中心, 中华医学会老年医学分会, 中国老年保健协会糖尿病专业委员会. 中国老年糖尿病诊疗指南(2021年版)[J]. 中华糖尿病杂志, 2021, 13(1):14-46.
[2] SINCLAIR A, SAEEDI P, KAUNDAL A, et al. Diabetes and global ageing among 65-99-year-old adults: findings from the international diabetes federation diabetes atlas, 9(th) edition[J]. Diabetes Res Clin Pract, 2020, 162:108078.
[3] KALYANI R R, SAUDEK C D, BRANCATI F L, et al. Association of diabetes, comorbidities, and A1C with functional disability in older adults: results from the National Health and Nutrition Examination Survey (NHANES), 1999-2006[J]. Diabetes Care, 2010, 33(5):1055-1060.
[4] FORBES A. Reducing the burden of mortality in older people with diabetes: a review of current research[J]. Front Endocrinol:Lausanne, 2020, 11:133.
[5] MUNSHI M N. Cognitive dysfunction in older adults with diabetes: what a clinician needs to know[J]. Diabetes Care, 2017, 40(4):461-467.
[6] MUNSHI M N, MENEILLY G S, RODRÍGUEZ-MAÑAS L, et al. Diabetes in ageing: pathways for developing the evidence base for clinical guidance[J]. Lancet Diabetes Endocrinol, 2020, 8(10):855-867.
[7] BLAUM C, CIGOLLE C T, BOYD C, et al. Clinical complexity in middle-aged and older adults with diabetes: the Health and Retirement Study[J]. Med Care, 2010, 48(4):327-334.
[8] KIRKMAN M S, BRISCOE V J, CLARK N, et al. Diabetes in older adults: a consensus report[J]. J Am Geriatr Soc, 2012, 60(12):2342-2356.
[9] LIPSKA K J, ROSS J S, MIAO Y, et al. Potential overtreatment of diabetes mellitus in older adults with tight glycemic control[J]. JAMA Intern Med, 2015, 175(3):356-362.
[10] LIBISELLER A, LICHTENEGGER K M, DE CAMPO A, et al. Diabetes management according to health status in older adults with type 2 diabetes staying in geriatric care facilities[J]. J Diabetes Sci Technol, 2021, 15(3):615-621.
[11] CHRISTIAENS A, BOLAND B, GERMANIDIS M, et al. Poor health status, inappropriate glucose-lowering therapy and high one-year mortality in geriatric patients with type 2 diabetes[J]. BMC Geriatr, 2020, 20(1):367.
[12] ROONEY M R, TANG O, ECHOUFFO TCHEUGUI J B, et al. American diabetes association framework for glycemic control in older adults: implications for risk of hospitalization and mortality[J]. Diabetes Care, 2021, 44(7):1524-1531.
[13] CIGOLLE C T, KABETO M U, LEE P G, et al. Clinical complexity and mortality in middle-aged and older adults with diabetes[J]. J Gerontol A Biol Sci Med Sci, 2012, 67(12):1313-1320.
[14] American Diabetes Association. Standards of medical care in diabetes--2012[J]. Diabetes Care, 2012, 35 (Suppl 1):S11-S63.
[15] American Diabetes Association. Older adults: standards of medical care in diabetes-2020[J]. Diabetes Care, 2020, 43(Suppl 1):S152-S162.
[16] American Diabetes Association. Older adults: standards of medical care in diabetes-2021[J]. Diabetes Care, 2021, 44(Suppl 1):S168-S179.
[17] DRAZNIN B, ARODA V R, BAKRIS G, et al. Older adults: standards of medical care in diabetes-2022[J]. Diabetes Care, 2022, 45(Supple1): S195-S207.
[18] LEROITH D, BIESSELS G J, BRAITHWAITE S S, et al. Treatment of diabetes in older adults: an endocrine society* clinical practice guideline[J]. J Clin Endocrinol Metab, 2019, 104(5):1520-1574.
[19] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2017年版)[J]. 中华糖尿病杂志, 2018, 10(1):4-67.
[20] WEINER J Z, GOPALAN A, MISHRA P, et al. Use and discontinuation of insulin treatment among adults aged 75 to 79 years with type 2 diabetes[J]. JAMA Intern Med, 2019, 179(12):1633-1641.
[21] CONLIN P R, COLBURN J, ARON D, et al. Synopsis of the 2017 U.S. Department of veterans affairs/U.S. department of defense clinical practice guideline: management of type 2 diabetes mellitus[J]. Ann Intern Med, 2017, 167(9):655-663.
[22] American Geriatrics Society Expert Panel on the Care of Older Adults with Diabetes Mellitus. Guidelines abstracted from the American Geriatrics Society guidelines for improving the care of older adults with diabetes mellitus: 2013 update[J]. J Am Geriatr Soc, 2013, 61(11): 2020-2026.
[23] Internatonal Diabetes Federation. Global guideline for managing older people with type 2 diabetes[EB/OL]. (2017-03-05) [2021-06-06]. https://www.idf.org/e-library/guidelines/78-global-guideline-for-managing-older-people-with-type-2-diabetes.html.
[24] BELLARY S, KYROU I, BROWN J E, et al. Type 2 diabetes mellitus in older adults: clinical considerations and management[J]. Nat Rev Endocrinol, 2021, 17(9):534-548.
[25] 吴孟娜, 冯磊, 罗旋, 等. 糖化血红蛋白与血糖的相关性[J]. 中国老年学杂志, 2022, 42(4):1019-1023.
[26] 李萌, 罗樱樱, 杨晓燕, 等.年龄对糖化血红蛋白和糖化血清白蛋白筛查糖尿病的影响[J].中国糖尿病杂志, 2015, 23(5):385-389.
[27] FREEMAN J. Management of hypoglycemia in older adults with type 2 diabetes[J]. Postgrad Med, 2019, 131(4):241-250.
[28] AMIEL S A, ASCHNER P, CHILDS B, et al. Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management[J]. Lancet Diabetes Endocrinol, 2019, 7(5): 385-396.
[29] GELLER A I, SHEHAB N, LOVEGROVE M C, et al. National estimates of insulin-related hypoglycemia and errors leading to emergency department visits and hospitalizations[J]. JAMA Intern Med, 2014, 174(5):678-686.
[30] POLONSKY W H, PETERS A L, HESSLER D. The impact of real-time continuous glucose monitoring in patients 65 years and older[J]. J Diabetes Sci Technol, 2016, 10(4):892-897.
[31] ABDELHAFIZ A H, RODRÍGUEZ-MAÑAS L, MORLEY J E, et al. Hypoglycemia in older people - a less well recognized risk factor for frailty[J]. Aging Dis, 2015, 6(2):156-167.
[32] UNGER J, KUSHNER P, ANDERSON J E. Practical guidance for using the free style libre flash continuous glucose monitoring in primary care[J]. Postgrad Med, 2020, 132(4):305-313.
[33] 唐伟, 张子成. 老年糖尿病血糖监测技术新进展[J]. 实用老年医学, 2022, 36(10):978-982.
[34] LEE S J, LEIPZIG R M, WALTER L C. Incorporating lag time to benefit into prevention decisions for older adults[J]. JAMA, 2013, 310(24):2609-2610.
[35] PILLA S J, SCHOENBORN N L, MARUTHUR N M, et al. Approaches to risk assessment among older patients with diabetes[J]. Curr Diab Rep, 2019, 19(8):59.
[36] LEE A K, STEINMAN M A, LEE S J. Improving the American diabetes association framework for individualizing treatment in older adults: evaluating life expectancy[J]. BMJ Open Diabetes Res Care, 2020, 8(1):e001624.
[37] ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes[J]. New Engl J Med, 2008, 358(24): 2560-2572.
[38] WONG M G, PERKOVIC V, CHALMERS J, et al. Long-term benefits of intensive glucose control for preventing end-stage kidney disease: advance-on[J]. Diabetes Care, 2016, 39(5): 694-700.
[39] 中华医学会内分泌学分会,中国成人2型糖尿病降压治疗目标研究工作组. 2型糖尿病患者认知功能障碍防治的中国专家共识[J]. 中华内分泌代谢杂志, 2022, 38(6):453-464.
[40] 王双, 詹俊鲲, 程梅, 等. 中国养老机构内老年人血糖规范化管理专家共识(2021)[J]. 中华老年医学杂志, 2021, 40(6):683-694.
[41] 赵元萍, 丁睿, 谢红. 中国版日常生活活动能力量表编制与信效度验证[J]. 实用老年医学, 2022, 36(12):1215-1219.
[42] SINCLAIR A J, HELLER S R, PRATLEY R E, et al. Evaluating glucose-lowering treatment in older people with diabetes: lessons from the IMPERIUM trial[J]. Diabetes Obes Metab, 2020, 22(8):1231-1242.
[43] GANDHI G Y, MOORADIAN A D. Management of hyperglycemia in older adults with type 2 diabetes[J]. Drugs Aging, 2022, 39(1):39-58.

老年2型糖尿病健康状态分层框架的应用与研究进展

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

Metrics

推荐阅读 10

[1]	王苏, 赵一璟, 魏晨敏, 陈堃, 曹雯, 王昆, 杨昱. 老年T2DM病人甘油三酯葡萄糖指数与低密度脂蛋白亚型的关系研究[J]. 实用老年医学, 2024, 38(10): 1002-1006.
[2]	顾崇怀, 项学军, 郑元喜, 乔锐, 林松. 达格列净对接受冠状动脉介入治疗的伴有射血分数降低的心力衰竭合并2型糖尿病老年病人疗效观察[J]. 实用老年医学, 2024, 38(10): 1025-1029.
[3]	周潇, 顾荣, 孔小岑, 罗勇, 王蔚萍, 马建华, 李惠琴. 桑枝总生物碱和卡格列净治疗血糖控制不佳的老年2型糖尿病病人的疗效观察[J]. 实用老年医学, 2024, 38(10): 1066-1069.
[4]	刘倩慧, 姚子俊, 何玉立, 徐云凡, 吴军. 老年2型糖尿病合并慢性心力衰竭病人HbA1c水平对心脏结构和功能的影响[J]. 实用老年医学, 2024, 38(5): 491-437.
[5]	刘童君, 赵雅洁, 胡洁玲, 胡洋, 梁伟. 糖代谢异常对血清激活素A水平的影响[J]. 实用老年医学, 2024, 38(5): 495-437.
[6]	杨龙璇, 唐伟. 细胞衰老与2型糖尿病胰岛B细胞功能障碍的研究进展[J]. 实用老年医学, 2024, 38(5): 521-437.
[7]	王金涛, 胡坚. 老年人2型糖尿病与肌少症的关系研究进展[J]. 实用老年医学, 2024, 38(5): 529-437.
[8]	唐源, 邓暑芳, 何咏梅, 戴雨璇, 罗晶. 老年2型糖尿病病人健康素养水平及其与衰弱的相关性[J]. 实用老年医学, 2024, 38(3): 255-259.
[9]	代玲俐, 俞匀. 老年2型糖尿病病人估计肾小球滤过率与胰岛素抵抗及胰岛B细胞功能的相关性研究[J]. 实用老年医学, 2023, 37(12): 1219-1223.
[10]	范婷泳, 袁丽, 杨小玲, 陈茜. Caprini量表评估老年糖尿病病人静脉血栓栓塞症的效果[J]. 实用老年医学, 2023, 37(12): 1233-1237.
[11]	张贺成, 魏苏. 老年2型糖尿病病人血清铁蛋白水平与糖尿病足发生的相关性[J]. 实用老年医学, 2023, 37(11): 1111-1114.
[12]	胡艳, 巫海娣, 王雪菲, 娄青林, 叶青, 顾刘宝, 戴静, 宋小波. 老年2型糖尿病病人糖尿病足风险评分与尿微量白蛋白/肌酐的相关性分析[J]. 实用老年医学, 2023, 37(11): 1134-1137.
[13]	张林英, 梅群超, 张炜琦, 胡一兰. 抗阻训练联合高乳蛋白营养在老年2型糖尿病伴肌少症病人中的应用研究[J]. 实用老年医学, 2023, 37(10): 995-999.
[14]	刘倩慧, 姚子俊, 何玉立, 吴军. SGLT2i对老年糖尿病病人心血管保护机制的研究进展[J]. 实用老年医学, 2023, 37(10): 1064-1068.
[15]	唐伟, 张子成. 人工智能在糖尿病诊疗中的研究进展[J]. 实用老年医学, 2023, 37(9): 882-885.